July 24, 2006
ANAHEIM, Calif.—Gencor Pacific (www.gencorpacific.com) received U.S. Patent No. 7,060,308, “Caralluma Extract products and processes for making the same”, covering its Caralluma fimbriata extract, marketed under the trade name SLIMALUMA. According to the company, the patent effort ensures SLIMALUMA customers receive the benefit of intellectual property protection and reinforces the company’s commitment to development of unique, functional ingredients.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023